StockData

RxSight, Inc. (RXST) stock

RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3075% below fair value
$5.01+0.18 (+3.73%)

Close on Nov 18, 2026Market cap $208.38MP/E –Yield –

RxSight shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

RxSight's shares outstanding was 41M at Jun 30, 2026. For fiscal 2025 it was 41M, up 5.1% from the year before. The highest annual figure on record is 41M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202541M+5.1%
FY2024Dec 31, 202439M+12.8%
FY2023Dec 31, 202334M+24.6%
FY2022Dec 31, 202228M+103.0%
FY2021Dec 31, 202114M+146.3%
FY2020Dec 31, 20206M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202641M+1.8%
Q1 FY2026Mar 31, 202641M+2.0%
Q4 FY2025Dec 31, 202541M+2.0%
Q3 FY2025Sep 30, 202541M+3.0%
Q2 FY2025Jun 30, 202541M+5.9%
Q1 FY2025Mar 31, 202541M+10.0%
Q4 FY2024Dec 31, 202440M+12.2%
Q3 FY2024Sep 30, 202440M+11.6%
Q2 FY2024Jun 30, 202438M+11.5%
Q1 FY2024Mar 31, 202437M+16.5%
Q4 FY2023Dec 31, 202336M+28.5%
Q3 FY2023Sep 30, 202336M+28.9%
Q2 FY2023Jun 30, 202334M+25.2%
Q1 FY2023Mar 31, 202332M+15.4%
Q4 FY2022Dec 31, 202228M+49.4%
Q3 FY2022Sep 30, 202228M+564.0%
Q2 FY2022Jun 30, 202228M+589.7%
Q1 FY2022Mar 31, 202227M–
Q3 FY2021Sep 30, 202119M–
Q2 FY2021Jun 30, 20214M–
Q1 FY2021Mar 31, 20214M–
Q3 FY2020Sep 30, 20200M–
Q2 FY2020Jun 30, 20200M–

More RxSight figures

See a number that looks wrong?